Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial
-
Published:2020
Issue:6
Volume:5
Page:e000979
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Lambertini MatteoORCID,
Agbor-Tarh Dominique,
Metzger-Filho Otto,
Ponde Noam F.,
Poggio FrancescaORCID,
Hilbers Florentine S.,
Korde Larissa A.,
Chumsri Saranya,
Werner Olena,
Del Mastro LuciaORCID,
Caparica Rafael,
Moebus Volker,
Moreno-Aspitia Alvaro,
Piccart Martine J.,
de Azambuja EvandroORCID
Subject
Cancer Research,Oncology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献